Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose aspirin for prevention of recurrent spontaneous preterm birth
NL-OMON47921Phase 3Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- May 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Spontaneous Preterm Birth (SPB) and preterm birth comparing Low-dose aspirin with Placebo (2 arms). Primary endpoint: Premature delivery. Started May 2016; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
Spontaneous Preterm Birth (SPB)preterm birth
Beyond the preview
Go deeper on NL-OMON47921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47921.